Mallinckrodt Submits INDA For Synacthen Depot

By: via Benzinga
Mallinckrodt plc (NYSE: MNK) revealed Monday that it submitted an Investigational New Drug (IND) application for Synacthen Depot to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.